Company Quick10K Filing
Viela Bio
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-K 2020-03-25 Annual: 2019-12-31
8-K 2020-03-25 Earnings, Exhibits
8-K 2020-01-10 Regulation FD, Exhibits

Viela Bio Financials

VIE Metrics, Comps, Filings

Annual | Quarterly

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($ Annual)

Operating, Investing, Financing

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Daniels Corporate Advisory (DCAC) 0 15% 0.1 -102% 936,967,000 4,067,677,000 3,597,267,000 549,105,000 -957,279,000 -927,187,000 -99,840,000
ATIF Holdings (ATIF) 110,482,523,000 0% 12,342,594,000 1,141,389,000 0 0 0 0 104,022,820,000
Vilacto Bio (VIBI) 0 17% -0.0 -3,636% 537,668,000 3,960,386,000 4,894,000 851,000 -19,550,169,000 -19,519,436,000 17,470,000
Rennova Health (RNVA) 0 8% -1.3 -236% 16,574,065,000 76,463,541,000 13,137,816,000 1,065,374,000 -39,131,999,000 -22,172,085,000 28,582,768,000
IGM Biosciences (IGMS) 430,671,651,000 -23.3 -4% 269,856,000,000 15,234,000,000 0 0 -10,172,000,000 -10,172,000,000 236,992,650,000
Kibush Capital (DLCR) 0 33% -0.2 -213% 178,215,000 3,451,816,000 140,487,000 46,120,000 -380,307,000 -373,628,000 88,172,000
Intercloud Systems (ICLD) 0 21% -1.3 -92% 9,928,000,000 40,762,000,000 10,074,000,000 2,119,000,000 -9,147,000,000 -8,136,000,000 10,297,000,000
Cerebain Biotech (CBBT) 0 -2.4 -7,969% 21,562,000 6,685,814,000 0 0 -1,718,373,000 -1,398,528,000 3,294,091,000
89bio (ETNB) 0.9 -102% 18,354,000,000 72,325,000,000 0 0 -18,725,000,000 -18,668,000,000 -16,226,002,000
HyperSolar (HYSR) 0 1.4 131% 173,934,000 6,527,958,000 0 0 227,646,000 1,247,098,000 1,711,471,000
Vir Biotechnology (VIR) 0% 6.8 -11% 422,642,000,000 66,827,000,000 1,403,000,000 0 -48,314,000,000 -47,427,000,000 -320,200,002,000
Data Call Technologies (DCLT) 0 70% 0.7 -21% 100,769,000 72,579,000 462,931,000 322,532,000 -20,717,000 -19,032,000 -13,413,000
Viela Bio (VIE) 3.2 -21% 233,840,000,000 493,500,000,000 0 0 -48,410,000,000 -48,410,000,000 -155,747,002,000
PropTech Acquisition Corp (PTACU)
Jiayin Group (JFIN)
10x Genomics (TXG) 4,804,979,012,000 75% -490.3 -2% 572,815,000,000 151,367,000,000 61,207,000,000 45,727,000,000 -9,603,000,000 -8,887,000,000 4,357,180,012,000
BridgeBio Pharma (BBIO) 2,745,038,752,000 0% -41.0 -9% 640,530,000,000 116,263,000,000 26,741,000,000 0 -60,733,000,000 -58,620,000,000 2,405,658,752,000
PetLife Pharmaceuticals (PTLF) 0 -0.1 -47,202% 7,856,000 1,980,970,000 0 0 -3,708,160,000 -3,708,160,000 205,072,000
ProGreen (PGUS) 0 0% -0.1 -176% 1,862,736,000 6,266,234,000 60,890,000 0 -3,277,294,000 -209,823,000 16,641,000
Yinghong Guangda Technology (UBLI) 0 24% 0.0 0 20,722,000 1,377,094,000 326,426,000 -1,328,558,000 -1,279,535,000 -1,000

Balance Sheet ($)
Cash
Accounts Receivable
Inventory
PP&E
Assets
Accounts Payable
Long-Term Debt
Liabilities
Stockholders' Equity
Income Statement ($)
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($)
Cash Operating
Cash Investing
Cash Financing